All In Biotech

Drug Trial Radar · NCT01400425

Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline

Last checked: Nov 19, 2026Latest source record: Mar 29, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

239

Actual

Start

Jul 2011

Primary completion

Jul 2012

Study completion Jul 2012

Sponsor

Lead sponsor
Avid RadiopharmaceuticalsIndustry
Sponsor type
Industry
First posted
Jul 22, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is designed to evaluate whether a florbetapir F 18 PET scan can impact clinical thinking when physicians are determining the likely cause of a subject's cognitive impairment.

Conditions

  • Progressive Cognitive Decline

Interventions

  • florbetapir F 18Drug

    IV injection, 370 megabecquerel (MBq) (10 millicurie \[mCi\]), single dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Subjects Who Undergo a Hypothetical Change in Clinical Diagnosis and Physician Management Plan After Obtaining a Negative Florbetapir F 18 PET Scan.Time frame: 6 weeks

Locations

18 sites in 1 country. Site status is shown where the registry gives one.

  • Research Site

    Phoenix, Arizona

  • Research Site

    Sun City, Arizona

  • Research Site

    San Francisco, California

  • Research Site

    Boulder, Colorado

  • Research Site

    Boynton Beach, Florida

  • Research Site

    Clearwater, Florida

  • Research Site

    Fort Myers, Florida

  • Research Site

    West Palm Beach, Florida

  • Research Site

    Shreveport, Louisiana

  • Research Site

    Quincy, Massachusetts

  • Research Site

    Las Vegas, Nevada

  • Research Site

    New York, New York

  • Research Site

    Patchogue, New York

  • Research Site

    Durham, North Carolina

  • Research Site

    Greensboro, North Carolina

  • Research Site

    Providence, Rhode Island

  • Research Site

    Providence, Rhode Island

  • Research Site

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.